Skip to main content

Perceptions of Daratumumab Therapy

Conference Correspondent 
Beth Faiman, PhD, APRN-BC, AOCN
Founding Editor in Chief
Beth Faiman sees daratumumab as a game changer for patients with multiple myeloma.

Related Items